RLYB

Rallybio Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 8/10
  • Value↑ 10/10
Rallybio sales and earnings growth
RLYB Growth
Good
  • Revenue Y/Y↑ 34.91%
  • EPS Y/Y↑ 85.01%
  • FCF Y/Y↑ 39.51%
Rallybio gross and profit margin trends
RLYB Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1046.40%
  • ROIC 5Y↓ -75.96%
Rallybio net debt vs free cash flow
RLYB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Rallybio stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗